Konrad Siegel
Bayer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Konrad Siegel.
Chemistry: A European Journal | 1998
Konrad Siegel; Reinhard Brückner
Dihydroxerulin (5) is a noncytotoxic inhibitor of cholesterol biosynthesis. In spite of being achiral and devoid of OH groups, it was synthesized efficiently in 2×5 steps in two linear sequences plus one terminating step, from the optically active, multiply hydroxylated L-gulonolactone via the key intermediates 1–4. 1H NMR spectroscopy revealed that the C8=C9 bond of synthetic and natural 5 is trans-substituted.
ChemInform | 1999
Christian Harcken; Thilo Berkenbusch; Stefan Braukmüller; Andreas Umland; Konrad Siegel; Felix Görth; Frank von der Ohe; Reinhard Brückner
Five-membered ring lactones abound in nature and have ever since challenged synthetic chemists.1,3 They comprise butanolides (1), butenolides (2), α-alkylidenebutanolides (3), and γ-alkylidenebutenolides (4; Fig. 1). We have developed versatile routes to such compounds. They encompass only a few steps and ensure a high degree of stereocontrol at all stereogenic sp 3 centers and C=C bonds. In addition they allow to vary the substituents R, R′, and R″ considerably. Therefore, we were able to synthesize butanolides and butenolides which differed structurally from one another distinctly.
Chemistry: A European Journal | 2005
Achim Sorg; Konrad Siegel; Reinhard Brückner
Synlett | 1999
Konrad Siegel; Reinhard Brückner
Archive | 2010
Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel
Archive | 2010
Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel
Archive | 2010
Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel
Archive | 2010
Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel
Archive | 2011
Gunter Karig; Mark James Ford; Konrad Siegel; Stefan Schnatterer
Synlett | 2004
Achim Sorg; Konrad Siegel; Reinhard Brückner